Medical/Pharmaceuticals
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...
2020-01-16 10:39
17783
FDF China to be held in June to boost Chinese pharmaceutical enterprises to "go global" and promote the innovation and development of industry
SHANGHAI, Jan. 16, 2020 /PRNewswire/ -- FDF China, collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the inte...
2020-01-16 09:52
1899
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"
SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...
2020-01-16 07:30
1294
Europ Assistance opens new office in Thailand
BANGKOK, Jan. 15, 2020 /PRNewswire/ -- Europ Assistance today announced the opening of their new office inBangkok, Thailand to provide its world-renowned travel and medical networks to the region and complete the presence of the Generali Group inThailand. This is part of their overall plan to acc...
2020-01-15 09:00
1821
ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China
SAN CARLOS, California, Jan. 14, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced that its ZAP-X® Gyroscopic Radiosurgery™ platform began clinical stereotactic radiosurgery (SRS) treatments at PLA General Hospital 301 (PLAGH 301) inBeijing, China. PLAGH 301 is the largest hospital ...
2020-01-14 23:07
2373
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada
SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced tha...
2020-01-14 08:00
15067
Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer
SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt,Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical ...
2020-01-14 08:00
2653
Evolution 2.0 Prize: Unprecedented $10 Million Offered To Replicate Cellular Evolution
CHICAGO, Jan. 14, 2020 /PRNewswire/ -- An incentive prize ten times the size of the Nobel – believed to be the largest single award ever in basic science – is being offered to the person or team solving the largest mystery in history: how genetic code inside cells got there, and how cells intent...
2020-01-14 03:23
1021
Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020
CHICAGO, Jan. 14, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare (IMSH 2020) inSan...
2020-01-14 03:15
904
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...
2020-01-13 22:00
6280
EW Nutrition Launches Revolutionary Enzyme in India
HYDERABAD, India, Jan. 13, 2020 /PRNewswire/ -- In December 2019, EW Nutrition has officially launched Axxess XY, a novel, intrinsically thermostable xylanase enzyme that delivers top performance to feed producers and the livestock industry. The revolutionary product was launched at a customer-ce...
2020-01-13 21:22
1084
COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression
LONDON, Jan. 13, 2020 /PRNewswire/ -- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers...
2020-01-13 19:05
1038
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry at ICSE China 2020
SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- The ICSE China 2020 will take place in Hall E2, E3/E7 of Shanghai New International Expo Centre fromJune 22-24, 2020. It will gather Chinese and overseas pharmaceutical experts, showcase advanced products and technologies in the CRO & CMO area and explore f...
2020-01-13 17:34
1755
Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe
Improved scan rates, higher resolution, and heightened sensitivity attract more verticals towards mass spectroscopy, finds Frost & Sullivan LONDON, Jan. 13, 2020 /PRNewswire/ -- A recent analysis of the mass spectrometry (MS) market inEurope by Frost & Sullivan has revealed that the sector will ...
2020-01-13 16:02
915
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss. CAMBRIDGE, England, Jan. 13, 2020 /PRNewswire/ -- Exonate, an early stage biotechnology com...
2020-01-13 16:00
1040
Nanoform Appoints Head of US Sales
HELSINKI, Jan. 13, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has appointedSally Langa as Head of US Sales. The new role will enable Nanoform to continue its rapid growth with a strengthened presence in the US market. As Head of US Sales, Sally Langa wil...
2020-01-13 15:21
899
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC
SUZHOU, China, Jan. 13, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...
2020-01-13 12:42
13369
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan
SINGAPORE, Jan. 13, 2020 /PRNewswire/ -- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar candidates inTaiwan and Hong Kong. The partnership covers Samsung Bioepis' biosimilar candidates in the field of immunology and oncology...
2020-01-13 10:02
2034
Skyrocketing growth tipped for China Medical industry over next 5 years; Medtec China 2020 upgrades to two halls to meet market needs
SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- According to a forecast from CIConsulting, the revenue ofChina's medical equipment and manufacturing industry will reachCNY327.4 billion in 2019, the average annual compound growth rate over the next five years will be about 8.15%, and the market will reach...
2020-01-13 09:00
3258
Say NO to Food Allergies, Taiwan User-Friendly Sensor & Tech (TFT) Creates Personalized Food Allergen Detection System
LAS VEGAS, Jan. 10, 2020 /PRNewswire/ -- Taiwan User-Friendly Sensor and Tech
(TFT) and other notable homegrown startups led by Taiwan Tech Arena (TTA) are
now showcasing their innovative solutions at CES 2020.
2020-01-11 00:00
1696
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
3839
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2974
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2971
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2855